Skip to content

Pilot Study: Feasibility and Usability of a Head-Mounted Spatial Computing Device for Intraoperative Visualization During Intraocular Surgery

Pilot Study: Feasibility and Usability of a Head-Mounted Spatial Computing Device for Intraoperative Visualization During Intraocular Surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07825337
Enrollment
70
Registered
2026-09-17
Start date
2026-08-30
Completion date
2028-08-30
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract Surgery

Keywords

Spatial computing, Augmented Reality, Cataract Surgery, Apple Vision Pro, Heads-up Display

Brief summary

To evaluate the feasibility and usability of Apple Vision Pro as an adjunct visualization and information display tool during ophthalmic surgery.

Detailed description

This is a prospective, observational, single-arm feasibility and usability study. Eligible adult patients undergoing clinically indicated intraocular surgery will have their surgeries performed according to standard of care, while the attending surgeon optionally uses Apple Vision Pro as an adjunct visualization device. No experimental procedures are performed on the patient, and standard microscopes and displays remain the primary visualization method. Approximately 40-70 surgeries will be observed across participating sites. Data will be collected intraoperatively and immediately postoperatively from the surgical record and from surgeon questionnaires.

Interventions

DEVICEApple Vision Pro Visualization System

Apple Vision Pro as an adjunct intraoperative visualization and information display tool during ophthalmic surgery.\[

Sponsors

Eric Rosenberg
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 years or older. * Undergoing clinically indicated, elective ophthalmic surgery (e.g., cataract, anterior segment, retina) at a participating study site. * Able and willing to provide informed consent prior to participation.

Exclusion criteria

* Prisoners or other vulnerable populations, unless specifically justified and approved by the IRB. * Inability to provide consent and no legally authorized representative available. * Cognitive impairment or language barriers precluding understanding of the consent, in the absence of a legally authorized representative. * Procedures where any additional OR equipment is judged by the surgeon to pose unacceptable risk. * Complex ocular pathology that could interfere with surgical visualization or increase procedural risk, including but not limited to lenticular zonule instability, previous ophthalmic surgery, corneal scarring, corneal opacity or edema, or active ocular surface infection.

Design outcomes

Primary

MeasureTime frameDescription
Continuity of care1 yearCompletion of surgery without device-related interruption that requires abandoning the surgery or conversion to an alternative procedure.
Questionnaire1 yearXR Usability Questionnaire (XR-UQ) scores for each case.

Countries

United States

Contacts

CONTACTKathy Lemier
eric@scopeXR.com6319573355

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026